The 30-day risks of hospitalization were 17.5%, 15.9%, and 14.4% for COVID, influenza, and RSV, respectively, during the 2022 ...

The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...

Human Metapneumovirus (HMPV) is a respiratory virus that can cause mild to severe respiratory issues. It spreads primarily ...

People with diabetes and obesity are at higher risk for severe respiratory illness caused by viruses, including serious ...

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...

Over 160,000 people this season have landed in the hospital from flu complications, CDC estimates. More than 6,600 have died.

Human Metapneumovirus (HMPV) is a respiratory virus that may not be on most folk’s radars, but it’s more common than you ...

The following is a summary of “Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study,” published in the January 2025 issue ...

Human metapneumovirus (hMPV) has been hitting the headlines recently as one of the lesser-known winter illnesses that can ...

Dr Nicholas Lipscomb said this winter has been particularly bad for RSV [BBC] Respiratory syncytial virus, or RSV, is one of ...

As winter takes hold in many parts of the world, there is a predictable rise in acute respiratory infections (ARIs). These increases are typically driven by seasonal epidemics of common pathogens ...

While the holiday season put a (deceptive) dent in the number of registered respiratory infections in Hungary, the ...